 |
|
|
| |
Switching to Doravirine/Islatravir (100 mg/0.25 mg) Once-Daily Maintained Viral Suppression in the Presence of Archived M184I/V Resistance–Associated Mutations in Proviral DNA
|
| |
| |
IAS July 13-17 Rwanda
Tracy L. Diamond1; Anjana Grandhi1; Monica Fuszard1; Yayun Xu1; Uchechukwu Nwoke1; Ying Zhang1; Stephanie Klopfer1; Karen Eves1; Jaime Benner1; Mengchun Li1; Wayne Greaves1; Rima Lahoulou2; Jason Kim1; Michelle C. Fox1; Ernest Asante-Appiah1*
1Merck & Co., Inc., Rahway, NJ, USA;
2MSD France, Puteaux, France
Download the PDF here
|
| |
|
|
|
|
|
